Age-related macular degeneration is an eye disease that can blur your central vision. It happens when aging causes damage to the macula — the part of the eye that controls sharp, straight-ahead vision. (Symbolic photo)
Keystone / Martin Ruetschi
An appeals court in France has overturned a record fine imposed by the French competition authority against the Swiss pharmaceutical companies Novartis and Roche.
This content was published on
2 minutes
Keystone-SDA/SWI/ug
Español
es
Se levantan las multas millonarias a los gigantes farmacéuticos
The verdict was announced by a court in Paris on Thursday.
Both firms were given a fine totaling €444 million (CHF438.9 million) in 2020 for following allegedly abusive practices, notably in the sale of the eye disease drug Lucentis at the expense of the Avastin drug treatment, which is up to 30 times cheaper.
Novartis was accused of conducting a communication campaign from 2008 to 2013 to discredit the use of Avastin in ophthalmology. The company was therefore fined the highest amount, €385 million, while Roche and its US subsidiary Genentech were fined €59 million.
In a first reaction, Novartis and Roche said they were “pleased” with the decision. They have denied allegations from the outset, arguing they acted appropriately in accordance with competition law and in the interests of patients at all times, according to the Swiss AWP news agency.
Different conclusion
The Paris court ruled that Avastin should be considered as no longer on the market from the time new legislation for the treatment of age-related macular degeneration came into effect in 2011.
The judges found that Novartis’ communications during the period under review were “moderate in tone”. They also found that the two companies’ communications had not been “alarmist or even misleading”.
Finally, the court held that the blocking behaviour of Roche, which had refused to provide Avastin samples requested by the health authorities for the launch of a scientific study, could not have had anti-competitive effects.
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
This content was published on
A Geneva-registered tourist plane grazed some ski mountaineers on Saturday on a glacier on the Swiss side of the Monte Rosa massif.
Sharp rise in reports of suspicious sports betting in Switzerland
This content was published on
Last year the Intercantonal Gambling Supervisory Authority received 184 reports of suspicious activities in connection with 166 sports competitions.
Swiss fencers apologise for diplomatic scandal with Israel
This content was published on
Two days after causing a diplomatic scandal at the U23 European Championships in Tallinn, the Swiss fencers responsible have published a jointly signed apology on Instagram.
Air in climbing gyms more polluted than on streets
This content was published on
The concentration of potentially harmful chemicals in climbing gyms is sometimes higher than on busy roads, say researchers from Switzerland and Austria.
This content was published on
Swiss International Air Lines (SWISS) achieved slightly higher sales at the start of the year. However, profits fell sharply, partly due to the late Easter.
Switzerland’s first padel court on water built in Arosa
This content was published on
Switzerland's first padel tennis court on water will open on the Obersee in Arosa, canton Graubünden, for the 2025 summer season.
This content was published on
Wine consumption in Switzerland fell by almost 8% in 2024 compared to the previous year. Swiss wines are particularly affected by the decline.
Jackie Chan to be honoured for life’s work at Locarno Film Festival
This content was published on
Martial artist Jackie Chan will receive an Honorary Leopard, a lifetime achievement award, from the Locarno Film Festival in southern Switzerland in August.
Novartis raises forecast again after strong Q1 results
This content was published on
Swiss pharmaceutical giant Novartis has continued the strong pace of growth of recent quarters in the first three months of 2025.
Swiss canton holds first general meeting on winegrowing
This content was published on
More than 250 professionals attended the first general meeting of the Valais wine industry on Monday in Conthey, western Switzerland.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss pharma industry fights lower drug prices in the US
This content was published on
A proposed US law aims to lower prescription drug prices. But Big Pharma is pulling out all the stops to lobby against it.
Swiss pharma giants fined by France in ongoing eye drug clash
This content was published on
Novartis and Roche have been fined by the French competition authority for applying abusive practices to push a costly eye injection drug.
High-priced medicine could be our best chance to lower drug prices
This content was published on
The best opportunity to rein in skyrocketing drug prices is coming from the most unlikely place – the highest priced therapies in the world.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.